Equity-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2012

Compensation Expense And Related Tax Benefit For Equity-Based Payments

	Three Months Ended				Six Months Ended
	June 30, 2012		July 2, 2011		June 30, 2012		July 2, 2011
Cost of sales	$	298	$	299	$	533	$	537
Selling and marketing		399		264		760		774
Research and development		434		347		822		694
General and administrative		3,114		2,570		5,930		4,945
Total compensation	$	4,245	$	3,480	$	8,045	$	6,950
Income tax benefit	$	1,766	$	1,201	$	2,786	$	2,398

Weighted-Average Assumptions Used For Grants Of Stock Options And SARs

	Six Months Ended
	June 30, 2012			July 2, 2011
Expected dividend yield		0	%		0	%
Forfeiture rate		10.21	%		11.50	%
Volatility		35.90	%		35.33	%
Risk free interest rate		.94	%		2.01	%
Range of interest rates		0.07% -1.95	%		0.01% -3.18	%
Expected weighted-average life		5.48 years			5.42 years
Fair value of stock appreciation rights (SARs) granted	$	5,490,000		$	5,347,000
Weighted-average grant date fair value of SARs granted	$	12.84		$	14.39

Summary Of SAR Activity

	Six Months Ended June 30, 2012
SARs	Shares			Weighted-Average Exercise Price
Outstanding at beginning of year		1,287,724		$	28.91
Granted		427,621			38.52
Exercised		(37,572	)		22.91
Forfeited		(16,606	)		33.67
Outstanding at end of period		1,661,167		$	31.47
Exercisable at end of period		572,231		$	26.36
Intrinsic value of exercised SARs	$	573,670

Summary Of Outstanding And Exercisable Options

	Outstanding						Exercisable
Range of Exercise Prices	Number of Shares		Weighted-Average Remaining Contractual Life		Weighted-Average Exercise Price		Number of Shares		Weighted-Average Exercise Price
$ 1.29-$36.49		477,100		4.59 years	$	32.25		471,414	$	32.41
$ 36.80-$41.25		384,646		4.81 years		39.80		384,646		39.80
$ 42.28-$45.62		401,316		3.24 years		44.51		401,316		44.51
$ 46.18-$51.62		374,856		2.45 years		48.63		374,856		48.63
$ 53.92-$53.92		1,800		1.91 years		53.92		1,800		53.92
		1,639,718						1,634,032

	Outstanding		Exercisable
Aggregate intrinsic value	$	2,421,000	$	2,318,000
Weighted-average remaining contractual term		3.8 years		3.8 years

Summary Of Stock Option Activity

	Six Months Ended June 30, 2012
Options	Shares			Weighted-Average Exercise Price
Outstanding at beginning of year		1,702,650		$	40.43
Granted		0			0.00
Exercised		(49,119	)		27.05
Forfeited		(1,663	)		36.36
Expired		(12,150	)		45.93
Outstanding at end of period		1,639,718		$	40.79
Exercisable at end of period		1,634,032		$	40.87
Intrinsic value of exercised options	$	546,203

Summary Of Restricted Stock Award Activity

	Six Months Ended June 30, 2012
Restricted Stock Awards	Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		836,141		$	28.34
Granted		231,311			38.62
Released		(205,702	)		20.31
Forfeited		(5,655	)		33.37
Outstanding at end of period		856,095		$	33.02

Summary Of Awards Granted Under Equity-Based Compensation Plans

	As of June 30, 2012
Awards granted under Zebra’s equity based compensation plans:
Unearned compensation costs related to awards granted	$	25,063,000
Period expected to be recognized over		2.8 years

Weighted-Average Assumptions Used For Employee Purchase Rights Granted Under Stock Purchase Plan

	Six Months Ended
	June 30, 2012			July 2, 2011
Fair market value	$	35.20		$	38.52
Option price	$	33.44		$	36.60
Expected dividend yield		0	%		0	%
Expected volatility		22	%		26	%
Risk free interest rate		0.04	%		0.11	%

Stock Appreciation Rights (SARs) [Member]

Summary Of Outstanding And Exercisable Options

	Outstanding						Exercisable
Range of Exercise Prices	Number of Shares		Weighted-Average Remaining Contractual Life		Weighted-Average Exercise Price		Number of Shares		Weighted-Average Exercise Price
$ 19.56-$19.56		387,075		6.77 years	$	19.56		272,497	$	19.56
$ 21.83-$27.50		57,014		7.35 years		24.83		39,708		24.55
$ 27.82-$27.82		413,710		7.80 years		27.82		137,065		27.82
$ 28.33-$40.10		461,104		9.67 years		38.05		24,755		35.17
$ 40.10-$42.36		342,264		8.81 years		41.61		98,206		41.70
		1,661,167						572,231

	Outstanding		Exercisable
Aggregate intrinsic value	$	11,705,000	$	6,670,000
Weighted-average remaining contractual term		8.3 years		7.5 years